Liang, Y;
Lyon, RC;
Pellman, J;
Bradford, WH;
Lange, S;
Bogomolovas, J;
Dalton, ND;
Gu, Y;
Bobar, M;
Lee, M-H;
et al.
Liang, Y; Lyon, RC; Pellman, J; Bradford, WH; Lange, S; Bogomolovas, J; Dalton, ND; Gu, Y; Bobar, M; Lee, M-H; Iwakuma, T; Nigam, V; Asimaki, A; Scheinman, M; Peterson, KL; Sheikh, F
(2021)
Desmosomal COP9 regulates proteome degradation in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
J Clin Invest, 131 (11).
e137689.
ISSN 1558-8238
https://doi.org/10.1172/JCI137689
SGUL Authors: Asimaki, Angeliki
Abstract
Dysregulated protein degradative pathways are increasingly recognized as mediators of human disease. This mechanism may have particular relevance to desmosomal proteins that play critical structural roles in both tissue architecture and cell-cell communication as destabilization/breakdown of the desmosomal proteome is a hallmark of genetic-based desmosomal-targeted diseases, such as the cardiac disease, arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). However, no information exists on whether there are resident proteins that regulate desmosomal proteome homeostasis. Here we uncovered a cardiac COP9 desmosomal resident protein complex, composed of subunit 6 of the COP9 signalosome (CSN6), that enzymatically restricted neddylation and targeted desmosomal proteome degradation. CSN6 binding, localization, levels and function were impacted in hearts of classic mouse and human models of ARVD/C impacted by desmosomal loss and mutations, respectively. Loss of desmosomal proteome degradation control due to CSN6 loss and human desmosomal mutations destabilizing CSN6 were also sufficient to trigger ARVD/C in mice. We identified a desmosomal resident regulatory complex that restricted desmosomal proteome degradation and disease.
Statistics
Item downloaded times since 07 Jun 2021.
Actions (login required)
![Edit Item](/style/images/action_view.png) |
Edit Item |